F-star Therapeutics, Inc. Common Stock
FSTX
FSTX was delisted on the 8th of March, 2023.
11 hedge funds and large institutions have $7.05M invested in F-star Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
50,279% more capital invested
Capital invested by funds: $14K → $7.05M (+$7.04M)
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
267% more funds holding
Funds holding: 3 → 11 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.01M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.83M |
| 3 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$1.79M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
+$891K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BBA
1
Baker Bros. Advisors
New York
| $1.75M | +$2.01M | +54,825 | New |
|
|
2
Alyeska Investment Group
Chicago,
Illinois
| $1.6M | +$1.83M | +50,000 | New |
|
|
PCM
3
Parsons Capital Management
Providence,
Rhode Island
| $1.56M | +$1.79M | +48,791 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $876K | +$1M | +27,411 | New |
|
|
SAM
5
Silvercrest Asset Management
New York
| $777K | +$891K | +24,322 | New |
|
|
DCM
6
DAFNA Capital Management
Los Angeles,
California
| $219K | +$251K | +6,853 | New |
|
|
WSFS
7
Wilmington Savings Fund Society
Wilmington,
Delaware
| $112K | +$128K | +3,500 | New |
|
|
VV
8
Verity & Verity
Beaufort,
South Carolina
| $99K | +$113K | +3,096 | New |
|
9
Morgan Stanley
New York
| $50K | +$57.3K | +1,563 | New |
|
10
Bessemer Group
Woodbridge,
New Jersey
| $10K | +$11.5K | +313 | New |
|
|
BIM
11
BlackRock Investment Management
Wilmington,
Delaware
| $1K | – | – | – |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$8K | -177 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$4K | -88 | Closed |
|
FSTX Hedge Fund Activity: Q4 2016 in Review
11 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q4 2016, worth a combined $7.05M — up 50,279% from $14K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FSTX positions and 2 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $2.01M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $8K sold.
- 11 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q4 2016, up from 3 in Q3 2016.
- Funds reported $7.05M of F-star Therapeutics, Inc. Common Stock stock for Q4 2016, up 50,279% quarter-over-quarter.
- 10 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q4 2016 and 2 closed out, a net change of +8 holders.
- The largest F-star Therapeutics, Inc. Common Stock buyer in Q4 2016 was Baker Bros. Advisors, an estimated $2.01M added.
- The largest F-star Therapeutics, Inc. Common Stock seller in Q4 2016 was Tower Research Capital (TRC), an estimated $8K sold.
Based on aggregated 13F filings for Q4 2016.